ZGC TEC LEASING (01601) entered into a financing lease agreement for the production equipment of traditional Chinese medicine.

date
22:14 23/03/2026
avatar
GMT Eight
Zhongguancun Technology Leasing (01601) issued an announcement that on March 23, 2026, the company, as the lessor, entered into a financial leasing agreement with lessee II Shandong Hongjitang Pharmaceutical Group Co., Ltd. According to this agreement, (i) the lessor will purchase leasing assets owned by lessee II at a transfer price of RMB 49 million; and (ii) the lessor will lease the assets back to lessee II for a lease term of 18 months, with total lease payments of approximately RMB 51.21 million, including a financial leasing principal of RMB 49 million and financial leasing interest income (including VAT) of approximately RMB 2.21 million.
ZGC TEC LEASING (01601) announced that on March 23, 2026, the company entered into a financial leasing agreement with lessee II Shandong Hongjitang Pharmaceutical Group Co., Ltd. As per the agreement, (i) the lessor will purchase the self-owned leasing assets of lessee II for a transfer price of RMB 49 million; and (ii) the lessor will lease back the leasing assets II to lessee II for a period of 18 months, with a total lease payment of approximately RMB 51.21 million, including the financial leasing principal of RMB 49 million and financial leasing interest income (including VAT) of approximately RMB 2.21 million. The leasing asset II is Chinese patent medicine production equipment, with a net book value of approximately RMB 51.23 million. The company's main business is providing financial leasing and consulting services to customers. Entering into financial leasing agreements is a part of the company's daily and general business, and is expected to bring in stable income and cash flow for the company.